JP2023524102A5 - - Google Patents
Info
- Publication number
- JP2023524102A5 JP2023524102A5 JP2022566628A JP2022566628A JP2023524102A5 JP 2023524102 A5 JP2023524102 A5 JP 2023524102A5 JP 2022566628 A JP2022566628 A JP 2022566628A JP 2022566628 A JP2022566628 A JP 2022566628A JP 2023524102 A5 JP2023524102 A5 JP 2023524102A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- abcb5
- cdr2
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063018440P | 2020-04-30 | 2020-04-30 | |
| US63/018,440 | 2020-04-30 | ||
| PCT/US2021/030342 WO2021222861A1 (en) | 2020-04-30 | 2021-04-30 | Antibodies specific to abcb5 and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524102A JP2023524102A (ja) | 2023-06-08 |
| JP2023524102A5 true JP2023524102A5 (cg-RX-API-DMAC7.html) | 2024-05-13 |
Family
ID=78373989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022566628A Pending JP2023524102A (ja) | 2020-04-30 | 2021-04-30 | Ａｂｃｂ５に特異的な抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230203153A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4142793A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023524102A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230034944A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116096753A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021262864A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3181591A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021222861A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019210109A1 (en) | 2018-04-25 | 2019-10-31 | Children's Medical Center Corporation | Abcb5 ligands and substrates |
| WO2020232247A1 (en) | 2019-05-14 | 2020-11-19 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| AU2020361622A1 (en) * | 2019-10-10 | 2022-04-28 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic viruses that express multi-specific immune cell engagers |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| IL308258A (en) | 2021-05-05 | 2024-01-01 | Immatics Biotechnologies Gmbh | Bma031 antigen binding polypeptides |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
| WO2025004683A1 (ja) * | 2023-06-30 | 2025-01-02 | 国立大学法人大阪大学 | がん検査方法及びがん治療剤 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1290028B1 (en) * | 2000-06-05 | 2009-12-23 | The Brigham And Women's Hospital, Inc. | A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| DK2155248T3 (en) * | 2007-04-12 | 2015-09-14 | Brigham & Womens Hospital | Targeting abcb5 for cancer therapy |
| WO2010065711A1 (en) * | 2008-12-04 | 2010-06-10 | Adimab, Inc. | An abcb5 epitope and antibodies thereto for the treatment of cancer |
| WO2016179576A1 (en) * | 2015-05-07 | 2016-11-10 | Bioxcel Corporation | Novel immunomodulatory therapeutic strategies targeting tumors in cancer |
| CN114245741A (zh) * | 2019-03-28 | 2022-03-25 | 儿童医学中心公司 | 高功能性的制造的abcb5+间充质干细胞 |
-
2021
- 2021-04-30 AU AU2021262864A patent/AU2021262864A1/en active Pending
- 2021-04-30 CA CA3181591A patent/CA3181591A1/en active Pending
- 2021-04-30 CN CN202180046044.6A patent/CN116096753A/zh active Pending
- 2021-04-30 KR KR1020227042053A patent/KR20230034944A/ko active Pending
- 2021-04-30 WO PCT/US2021/030342 patent/WO2021222861A1/en not_active Ceased
- 2021-04-30 US US17/922,286 patent/US20230203153A1/en active Pending
- 2021-04-30 JP JP2022566628A patent/JP2023524102A/ja active Pending
- 2021-04-30 EP EP21796792.6A patent/EP4142793A4/en active Pending